Virginia Focus - Medicare & Alzheimers Meds
27 ott 2023 ·
29 min. 30 sec.
![Virginia Focus - Medicare & Alzheimers Meds](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/0c855afcedb4a5c5826a4612db1fad22.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
More than six million Americans are currently living with Alzheimer's disease and by 2050, that number is expected to skyrocket to 13 million. The FDA approved two new treatments that...
mostra di più
More than six million Americans are currently living with Alzheimer's disease and by 2050, that number is expected to skyrocket to 13 million. The FDA approved two new treatments that slow the progression of the disease, but the Centers for Medicare and Medicaid Services, also known as CMS, is setting a dangerous precedent by requiring consent from patients in a way that's never been demanded before. Now many doctors, elected leaders, and families are afraid patients will face health disparities and that the move could be expanded to limit access to other medications. Let's hear more from the Chairman of the Partnership to Fight Chronic Disease and Chairman of Health Policy and Management at Emory University, Dr. Kenneth Thorpe.
mostra meno
Informazioni
Autore | 640 WGST (WGST-AM) |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company